Skip to main content

Advertisement

Table 2 List of MHC class I-restricted peptides used as stimuli

From: Longitudinal changes in HIV-specific IFN-γ secretion in subjects who received Remune™ vaccination prior to treatment interruption

Peptide ID Sequence Location Sequence MHC Restriction (s)
A1-1 p17 (71–79) GSEELRSLY A1
A1-2 Nef (121–128) FPDWQNYT A1
A1-3 Nef (184–192) RFDSRLAFH A1
A2-1 p17 (77–85) SLYNTVATL A2
A2-2 RT (309–317) ILKEPVHGV A2
A2-3/A3-1 Nef (190–198) AFHHVAREL A2, A3
A2-4 p24 (19–27) TLNAWVKVV A2
A2-5 RT (179–187) VIYQYMMDL A2
A2-6 CMV NLVPMVATV A2
A3-2 EBV IVTDFSVIK A3, A11, A6801
B7-1 p24 (47–56) ATPQDLNTML B7, B58
B7-2 p24 (16–24) SPRTLNAWV B7
B7-3/B35-1 Nef (68–77) FPVTPQVPLR B7, B35
B7-4 Nef (128–137) TPGPGVRYPL B7
B7-5 CMV TPRVTGGGAM B7
B7-6 EBV RPPIFIRRL B7
B8-1 p24 (127–135) GEIYKRWII B8
B8-2 Nef (90–97) FLKEKGGL B8
B8-3 p17 (24–31) GGKKKYKL B8
B8-4 RT (18–26) GPKVKQWPL B8
B8-5 p17 (93–101) EIKDTKEAL B8, B60
B8-6 EBV FLRGRAYGL B8
B35-2 RT (175–183) HPDIVIYQY B35
B35-3 gp160 (41–51) GVPVWKEATTT B35
B35-4/B7-7 RT (156–166) SPAIFQSSMTK A3, A3.1, A11, A6801, A33, B7, B35
B35-5 Nef (73–82) QVPLRPMTYK A3, A11, A31, B27, B35
B44-1 p24 (174–184) AEQASQDVKNW B44, B57, Cw4
B44-2 p24 (162–172) RDYVDRFYKTL B18, B2601, B44, B70
B44-3 RT (203–212) EELRQHLLRW B44
B44-4 RT (397–406) TWETWWTEYW B44
Cw7-1 gp160 (37–46) TVYYGVPVWK A3, A6801, A11, Cw7